Molnupiravir

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 23:17, October 25, 2021 by Notjusttired (talk | contribs) (create)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Molnupiravir is a new antiviral drug which has recently undergone clinical trials for COVID-19 treatment, and other uses.[1][2]

Theory

Evidence

There is no evidence yet of the use of molnupiravir in patients with ME/CFS.

Clinicians

Risks and safety

Largely unknown. Molnupiravir is not yet approved as safe for human use.[1]

Costs and availability

Molnupiravir is not yet FDA-approved, although approval is likely in 2022. Molnupiravir is taken orally.[3]

Articles and news

Notable studies

See also

Learn more

References

  1. ↑ 1.0 1.1 https://go.drugbank.com/drugs/DB15661
  2. ↑ https://www.drugs.com/history/molnupiravir.html
  3. ↑ https://www.webmd.com/vaccines/covid-19-vaccine/news/20210924/a-daily-pill-to-treat-covid-could-be-just-months-away-scientists-say
Retrieved from "https://me-pedia.org/w/index.php?title=Molnupiravir&oldid=93660"